Side-by-Side Comparison
| Metric | Molecure | Syntara |
|---|---|---|
| Founded | ||
| Founded | 2012 | 1998 older |
| Headquarters | ||
| Headquarters | Warsaw, Poland | Australia |
| Employees | ||
| Employees | 85 | 58 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post-IPO Secondary | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $50.00M | $1.39M |
| Funding Rounds | ||
| Funding Rounds | 1 | 1 |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalClinical StageSmall Molecule Drug DiscoveryImmunotherapyMedicinal ChemistryRespiratory Diseases +9 | Clinical Stage Drug DevelopmentExtracellular Matrix DysfunctionAmine Oxidase ChemistryDrug CandidatesFibrotic DiseasesInflammatory Diseases +9 |
| Website | ||
| Website | molecure.com | syntaratx.com.au |
About Molecure
Molecure is a clinical stage biopharmaceutical company based in Poland. Since its establishment in 2012, the company has been dedicated to utilizing its world-leading medicinal chemistry capabilities to address unmet medical needs. Molecure's approach involves discovering and developing first-in-cla...
About Syntara
Syntara (ASX:SNT) is a clinical stage drug developer focusing on diseases associated with fibrosis and inflammation. The company, founded in 1998, specializes in targeting extracellular matrix dysfunction using its expertise in amine oxidase chemistry. Its lead candidate SNT-5505 has received FDA Or...
Also comparing in this category
Comparing more than these two?
Get Molecure, Syntara and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Molecure compare?
A PDF of Molecure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Molecure with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Molecure on 12 Sep 2024, and Syntara on 6 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.